In silico solutions for biopharma R&D

From data to targets & biomarkers, therapeutics, and trial designs.
Powered by gen AI, computational biology, computational chemistry, and cloud.

De-risking & accelerating drug discovery with precision target and biomarker identification, assessment & validation

AI-powered drug discovery platform for faster and cost-effective de novo small molecule design

Accelerating antibody engineering with in silico solutions

Advancements in RNA-based therapeutics centered on the regulation of gene expression

Advancements in gene and cell therapy with innovative science and technology approaches

GenAI powered in silico enzyme characterization and optimization

Machine learning-powered computational chemistry methods to predict reaction yields

Offering services in computational sciences and technology to complement biopharma R&D

Helping clients accelerate drug discovery and development by building computational biology, computational chemistry, technology, and cloud solutions

Flexible engagement models catering to customer’s specific requirements

Discover our offerings across the biopharma value chain